Inhibitors of catechol-O-methyltransferase in the treatment of neurological disorders.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Central Nervous System Agents in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.2174/1871524913666140109113341PMID 24450388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads.

  2013cited by this paper
• Catechol metabolites of the mycotoxin zearalenone are poor substrates but potent inhibitors of catechol-O-methyltransferase

  2013cited by this paper
• Inhibitors of Catechol-O-Methyltransferase.

  2012cited by this paper
• Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates.

  2012cited by this paper
• The Relationship between the Val158Met Catechol-o-Methyltransferase (COMT) Polymorphism and Irritable Bowel Syndrome

  2011cited by this paper
• Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.

  2011cited by this paper
• Discovery of a long-acting, peripherally selective inhibitor of catechol-O-methyltransferase.

  2010cited by this paper
• Inhibition of catechol-O-methyltransferase (COMT) by some plant-derived alkaloids and phenolics

  2010cited by this paper
• Design, synthesis and in vitro/in vivo evaluation of orally bioavailable prodrugs of a catechol-O-methyltransferase inhibitor.

  2010cited by this paper
• Catechol‐O‐Methyl Transferase Inhibitors. In Vitro Inhibition of the Enzyme in Mouse‐Brain Extract

  2009cited by this paper
• Molecular recognition at the active site of catechol-o-methyltransferase: energetically favorable replacement of a water molecule imported by a bisubstrate inhibitor.

  2009cited by this paper
• Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

  2009cited by this paper
• Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee.

  2009cited by this paper
• Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: The Nord-Trøndelag Health Study (HUNT)

  2008cited by this paper
• Crystal structures of human 108V and 108M catechol O-methyltransferase.

  2008cited by this paper
• The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction.

  2007cited by this paper
• Relationship of catechol-O-methyltransferase to schizophrenia and its correlates: evidence for associations and complex interactions.

  2007cited by this paper
• Catechol-O-methyltransferase and its inhibitors in Parkinson's disease.

  2007cited by this paper
• Identification of COMT and ErmC inhibitors by using a microplate assay in combination with library focusing by virtual screening.

  2006cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• Meta-analysis of Association Between a Catechol-O-Methyltransferase Gene Polymorphism and Attention Deficit Hyperactivity Disorder

  2006cited by this paper
• Inhibitory effects of catechin gallates on o-methyltranslation of protocatechuic acid in rat liver cytosolic preparations and cultured hepatocytes.

  2005cited by this paper
• Comparative homology modeling and ligand docking study of human catechol-O-methyltransferase for antiparkinson drug design

  2005cited by this paper
• Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase.

  2005cited by this paper
• Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies.

  2005cited by this paper
• Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.

  2005cited by this paper
• Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism

  2004cited by this paper
• Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• COMT: A common susceptibility gene in bipolar disorder and schizophrenia

  2004influential reference
• Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Bisubstrate Inhibitors of the Enzyme Catechol O‐Methyltransferase (COMT): Efficient Inhibition Despite the Lack of a Nitro Group

  2004cited by this paper
• A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods

  2003cited by this paper
• Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.

  2003cited by this paper
• Multimeric threading-based prediction of protein-protein interactions on a genomic scale: application to the Saccharomyces cerevisiae proteome.

  2003cited by this paper
• Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application.

  2002cited by this paper
• Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.

  2001cited by this paper
• Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach

  2001cited by this paper
• Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.

  2001cited by this paper
• X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity.

  2001cited by this paper
• AdoMet-dependent methylation, DNA methyltransferases and base flipping.

  2001cited by this paper
• Central Nervous System Depressants

  2000cited by this paper
• Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.

  2000cited by this paper
• Effects of tea consumption on nutrition and health.

  2000cited by this paper
• Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).

  2000cited by this paper
• O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.

  2000cited by this paper
• Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

  1999cited by this paper
• Depression in Parkinson’s Disease

  1998cited by this paper
• Ascorbic Acid Inhibits Spinal Meningeal Catechol‐o‐Methyl Transferase in Vitro, Markedly Increasing Epinephrine Bioavailability

  1997cited by this paper
• Catechol‐O‐methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families

  1997cited by this paper
• Synthesis and in vitro evaluation of two progressive series of bifunctional polyhydroxybenzamide catechol-O-methyltransferase inhibitors.

  1997cited by this paper
• Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder.

  1997cited by this paper
• Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior.

  1997cited by this paper
• The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.

  1996cited by this paper
• Bioactive 6-Nitronorepinephrine Identified in Mammalian Brain*

  1996cited by this paper
• Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

  1995cited by this paper
• Distribution of catechol-O-methyltransferase enzyme in rat tissues.

  1994cited by this paper
• Crystal structure of catechol O-methyltransferase

  1994cited by this paper
• Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

  1994cited by this paper
• Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone.

  1994cited by this paper
• Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione.

  1993cited by this paper
• Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo.

  1993cited by this paper
• PLS modelling of structure—activity relationships of catechol O-methyltransferase inhibitors

  1992cited by this paper
• Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.

  1992cited by this paper
• Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters.

  1992cited by this paper
• Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA

  1991cited by this paper
• Effects of the COMT inhibitor, CGP 28014, on plasma homovanillic acid and O-methylation of exogenous L-dopa in the rat.

  1990cited by this paper
• CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

  1990cited by this paper
• Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide.

  1990cited by this paper
• Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors.

  1989cited by this paper
• QSAR and Binding Model for Inhibition of Rat Liver Catechol-O-Methyl-Transferase by 1,5-Substituted-3,4-Dihydroxybenzenes

  1989cited by this paper
• Catechol-O-methyltransferase-inhibiting pyrocatechol derivatives: synthesis and structure-activity studies

  1989cited by this paper
• New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

  1989cited by this paper
• Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

  1988cited by this paper
• Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase.

  1988cited by this paper
• Inhibition of Catechol‐O‐Methyltransferase by 6,7‐Dihydroxy‐3,4‐Dihydroisoquinolines Related to Dopamine: Demonstration Using Liquid Chromatography and a Novel Substrate for O‐Methylation

  1987cited by this paper
• Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.

  1986cited by this paper
• Synthesis of bridged catechol-homocysteine derivatives as potential inhibitors of catechol O-methyltransferase.

  1984cited by this paper
• Kinetics of rat brain soluble catechol-O-methyltransferase and its inhibition by substrate analogues.

  1983cited by this paper
• Catechol O-methyltransferase. 10. 5-Substituted 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors.

  1982cited by this paper
• Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole.

  1982cited by this paper
• Synthesis and evaluation of some stable multisubstrate adducts as inhibitors of catechol O-methyltransferase.

  1981cited by this paper
• Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance.

  1980cited by this paper
• Stereochemical course of the transmethylation catalyzed by catechol O-methyltransferase.

  1980cited by this paper
• .alpha.-Deuterium and carbon-13 isotope effects for methyl transfer catalyzed by catechol O-methyltransferase. SN2-like transition state

  1979cited by this paper
• Biochemical activities of the derivatives of dehydrodicaffeic acid dilactone.

  1978cited by this paper
• Catechol O-methyltransferase. 9. Mechanism of inactivation by 6-hydroxydopamine

  1977cited by this paper
• Catechol O-methyltransferase. 8. Structure-activity relationships for inhibition by 8-hydroxyquinolines

  1976cited by this paper
• Letter: General base catalysis in nucleophilic attack at sp3 carbon of methylase model compounds.

  1976cited by this paper
• Catechol O-methyltransferase. 7. Affinity labeling with the oxidation products of 6-aminodopamine.

  1976cited by this paper
• Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 4. Further modifications of the amino and base portions of S-adenosyl-L-homocysteine.

  1976cited by this paper
• New isoflavones, inhibiting catechol-O-methyltransferase, produced by Streptomyces.

  1975cited by this paper
• Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 3. Modifications of the sugar portion of S-adenosylhomocysteine.

  1975cited by this paper
• Catechol-O-methyl transferase: pharmacological aspects and physiological role.

  1975cited by this paper
• Analogs of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Inhibition of several methylases by S-tubercidinylhomocysteine.

  1974cited by this paper
• Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine.

  1974cited by this paper
• Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 2. Modification of the base portion of S-adenosylhomocysteine

  1974cited by this paper
• Catechol O-methyltransferase. 3. Mechanism of pyridoxal 5'-phosphate inhibition.

  1973cited by this paper
• Letter: 7-0-methylspinochrome B and its 6-(3-hydroxy-N-butyl)-derivative, catechol-O-methyl transferase inhibitors, produced by Fungi imperfecti.

  1973cited by this paper

• New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

  2025cites this paper
• Natural plant materials as a source of neuroprotective peptides.

  2023cites this paper
• Inhibitory activity of catecholic phosphonic and phosphinic acids against Helicobacter pylori ureolysis.

  2023cites this paper
• Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.

  2022cites this paper
• A systematic review of the O-methyltransferase gene expression

  2021cites this paper
• Discovery and characterization of naturally occurring potent inhibitors of catechol-O-methyltransferase from herbal medicines

  2021cites this paper
• Discovery and characterization of flavonoids in vine tea as catechol-O-methyltransferase inhibitors.

  2021cites this paper
• Evidence to Support the Use of S-Adenosylmethionine for Treatment of Post-Concussive Sequelae in the Military.

  2021cites this paper
• Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder

  2021cites this paper
• Whether short peptides are good candidates for future neuroprotective therapeutics?

  2021cites this paper
• Catechol-O-Methyltransferase Inhibitors Isolated From Thai Propolis

  2021influential citation
• Insight into the Therapeutic Potential of a Bicyclic Hydroxypyridone Compound 2‐[(2,4‐Dichlorophenyl)methyl]‐7‐hydroxy‐1,2,3,4‐tetrahydro‐8H‐pyrido[1,2‐a]pyrazin‐8‐one as COMT Inhibitor in the Treatment of Parkinson's Disease: A Molecular Dynamic Simulation Approach

  2021cites this paper
• Search for safer and potent natural inhibitors of Parkinson's disease.

  2021cites this paper
• Neuroprotective Effects, Biological Activities and Therapeutic Potential of Phytochemicals: A Comprehensive Review

  2020cites this paper
• Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications

  2020cites this paper
• Neurological and psychiatric management using COMT inhibitors: A review.

  2019cites this paper
• Fluorescent probes for bioactive detection and imaging of phase II metabolic enzymes

  2019cites this paper
• Development of a PC12 Cell Based Assay for Screening Catechol-O-methyltransferase Inhibitors

  2019cites this paper
• Development of a PC12 cell-based assay for in vitro screening of catechol-O-methyltransferase inhibitors

  2019cites this paper
• Anxiety and genetic polymorphisms in catechol-O-methyltransferase (COMT) and serotonin transportation gene (5HTT) are associated with benign migratory glossitis.

  2019cites this paper
• Interspecies comparison in the COMT-mediated methylation of 3-BTD

  2018cites this paper
• Advantages of Structure-Based Drug Design Approaches in Neurological Disorders

  2017cites this paper
• Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites

  2017cites this paper
• An Optimized Two-Photon Fluorescent Probe for Biological Sensing and Imaging of Catechol-O-Methyltransferase.

  2017cites this paper
• Metabolic and Performance Effects of Yerba Mate on Well-trained Cyclists

  2017cites this paper
• Current treatments in Parkinson's including the proposal of an innovative dopamine microimplant

  2016cites this paper
• A highly selective fluorescent probe for sensing activities of catechol-O-methyltransferase in complex biological samples

  2016cites this paper
• Chemical Proteomic Profiling of Human Methyltransferases.

  2016cites this paper
• Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

  2014cites this paper
• Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.

  2014cites this paper